Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edwards Lifesciences Corp EW

Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter... see more

Recent & Breaking News (NYSE:EW)

How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED

PR Newswire June 8, 2016

Edwards Lifesciences To Present At Goldman Sachs 37th Annual Global Healthcare Conference

PR Newswire May 31, 2016

Jury Finds in Favor of CardiAQ in Case with Neovasc

PR Newswire May 19, 2016

Edwards' Surgical Heart Valve Innovations Demonstrate Positive Patient Benefits

PR Newswire May 17, 2016

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

PR Newswire May 17, 2016

Edwards Lifesciences' Philanthropy Impacts 200,000 Underserved Patients Through Every Heartbeat Matters Initiative

PR Newswire May 11, 2016

Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

PR Newswire May 5, 2016

Edwards Lifesciences To Present At The Deutsche Bank 41st Annual Health Care Conference

PR Newswire May 2, 2016

Edwards Lifesciences Reports First Quarter Results

PR Newswire April 26, 2016

Edwards Lifesciences To Host Earnings Conference Call On April 26, 2016

PR Newswire April 12, 2016

Edwards SAPIEN 3 TAVR Demonstrates Clinical Superiority To Surgery In PARTNER II Study

PR Newswire April 3, 2016

Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial

PR Newswire April 2, 2016

Steven Loranger Appointed To Edwards Lifesciences Board Of Directors

PR Newswire March 17, 2016

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

PR Newswire March 16, 2016

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

PR Newswire March 2, 2016

Edwards Lifesciences Announces $325 Million Accelerated Share Repurchase

PR Newswire February 4, 2016

Edwards Lifesciences To Present At The Leerink Global Healthcare Conference

PR Newswire February 3, 2016

Edwards Lifesciences Reports Fourth Quarter Results

PR Newswire February 2, 2016

Edwards Lifesciences To Host Earnings Conference Call On February 2, 2016

PR Newswire January 21, 2016

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

PR Newswire January 15, 2016